Screening for Intracranial Aneurysms in Coarctation of the Aorta: A Decision and Cost-Effectiveness Analysis.

BACKGROUND: Patients with coarctation of the aorta have a high prevalence of intracranial aneurysms (IA) and suffer subarachnoid hemorrhage (SAH) at younger ages than the general population. American Heart Association/American College of Cardiology guidelines recommend IA screening, but appropriate age and interval of screening and its effectiveness remain a critical knowledge gap. METHODS AND RESULTS: To evaluate the benefits and cost-effectiveness of magnetic resonance angiography screening for IA in patients with coarctation of the aorta, we developed and calibrated a Markov model to match published IA prevalence estimates. The primary outcome was the incremental cost-effectiveness ratio. Secondary outcomes included lifetime cumulative incidence of prophylactic IA treatment and mortality and SAH deaths prevented. Using a payer perspective, a lifetime horizon, and a willingness-to-pay of $150 000 per quality-adjusted life-year gained, we applied a 3% annual discounting rate to costs and effects and performed 1-way, 2-way, and probabilistic sensitivity analyses. In a simulated cohort of 10 000 patients, no screening resulted in a 10.1% lifetime incidence of SAH and 183 SAH-related deaths. Screening at ages 10, 20, and 30 years led to 978 prophylactic treatments for unruptured aneurysms, 19 procedure-related deaths, and 65 SAH-related deaths. Screening at ages 10, 20, and 30 years was cost-effective compared with screening at ages 10 and 20 years (incremental cost-effectiveness ratio $106 841/quality-adjusted life-year). Uncertainty in the outcome after aneurysm treatment and quality of life after SAH influenced the preferred screening strategy. In probabilistic sensitivity analysis, screening at ages 10, 20, and 30 years was cost-effective in 41% of simulations and at ages 10 and 20 in 59% of simulations. CONCLUSIONS: Our model supports the American Heart Association/American College of Cardiology recommendation to screen patients with coarctation of the aorta for IA and suggests screening at ages 10 and 20 or at 10, 20, and 30 years would extend life and be cost-effective.

Avaliação da resposta clínica, inflamatória e infecciosa de crianças submetidas à cirurgia de coarctação da aorta com ou sem uso de precondicionamento isquêmico por pinçamento da aorta torácica descendente / Assessment of clinical, inflammatory and infectious response in children undergoing surgery for aortic coarctation with or without ischemic preconditioning by clamping of the descending thoracic aorta

O precondicionamento isquêmico é o mais poderoso método experimental de proteção celular e pode ser aplicado em cirurgias que ocasionem isquemia tecidual como na correção de coarctação da aorta. Objetivo: Avaliar os resultados clínicos, inflamatórios e infecciosos de crianças submetidas à cirurgia de coarctação da aorta com ou sem uso de precondicionamento isquêmico por pinçamento da aorta torácica. Como desfechos primários foram avaliados os Eventos Adversos Principais (EAP) e o óbito em até 30 dias. Método: Foram analisados retrospectivamente os dados clínicos de 104 pacientes submetidos consecutivamente a cirurgia de coarctação da aorta entre dezembro de 2007 e dezembro de 2012 no Instituto Nacional de Cardiologia, Centro Pediátrico da Lagoa e Hospital Prontobaby na cidade do Rio de Janeiro. Foram constituídos dois grupos, G PRE: 27 pacientes submetidos ao precondicionamento e G CONT: 77 pacientes de controle. Resultados: Houve predomínio do sexo masculino, 62,5 por cento, a média de peso foi de 4,04±3,07 kg e 11,53 por cento tinham peso < 2,5kg. A média de idade foi de 3,82±2, com mediana de 1,04 meses. A cirurgia foi realizada em caráter de emergência em 81,48 por cento no G PRE (p<0,001) e o Basic e o Comprehensive Aristotle Score foram maiores no G CONT (p<0,001). A bandagem da artéria pulmonar foi realizada em 37,9 por cento do G PRE contra 9,09 por cento do G CONT e 81,48 por cento do G PRE tiveram anastomose estendida no arco aórtico (p<0,001). As complicações aconteceram em 66,23 por cento no G CONT e em 22,22% no G PRE (p<0,001)...

Ischemic preconditioning is the most powerful experimental method for cellprotection and can be applied in surgeries which result in tissue ischemia as correction ofcoarctation of the aorta.Objective: To evaluate the clinical, inflammatory and infectious in children undergoingsurgery for aortic coarctation with and without ischemic preconditioning. As primaryoutcomes will be Major Adverse Events (MAE) and death within 30 days.Methods: We retrospectively evaluated the clinical data of 104 consecutive patientsundergoing surgery for aortic coarctation between December 2007 and December 2012 at theInstituto Nacional de Cardiologia, Centro Pediátrico da Lagoa e Hospital Prontobaby in thecity of Rio de Janeiro. Two groups were composed, G PRE: 27 patients underwentpreconditioning and G CONT: 77 control patients.Results: Male gender were 62.5 percent, the mean weight was 4.04±3.07 kg and 11.53 percent hadweight <2.5 kg. The mean age was 3.82 ± 2.05 with a median of 1.04 months. The G PREhad 81.48% of emergency surgeries (p <0.001) and Basic and Comprehensive Aristotle scorewere higher in G PRE (p <0.001). Pulmonary artery banding was performed in 37.9 percent of GPRE and in 9.09 percent of G CONT and 81.48 percent of G PRE had extended aortic arch anastomosis(p <0.001)...

Open, hybrid, and endovascular treatment for aortic coarctation and postrepair aneurysm in adolescents and adults.

BACKGROUND: Open, hybrid, and endovascular procedures are used for grown-up patients with aortic coarctation and complications after repair, an expanding population. We sought to characterize patients and procedures, assess early and late outcomes, and describe indications to guide treatment of these complex patients. METHODS: Between May 1999 and January 2011, 110 patients underwent open (n=40), hybrid (n=11), or endovascular (n=59) repair of coarctation (n=43), recurrent aortic coarctation (n=42), or postrepair aneurysm (n=25). Mean age was 38±14 years. Sixty-eight had previous repairs (median 27 years earlier; range, 1 to 50). Twenty-two had prior cardiovascular operations other than coarctation and 50% had bicuspid valve. Fifty-nine concomitant procedures were performed in 45 patients (40%). Data were from the prospective database, chart review, and Social Security Death Index. RESULTS: Technical success was achieved in 100%, with no hospital deaths, no strokes, and no paraplegia. Complications were uncommon and included respiratory failure (n=2, 1.8%), and temporary renal failure (n=2, 1.8%). Twenty-two patients required reinterventions, but half of those were planned. There was no difference in occurrence of unplanned reintervention between approaches (endovascular 12%, hybrid 18%, open 12.5%). Length of stay was 4.8±4.8 days. Transcoarct gradient fell from 37.6±18 mm Hg preoperatively to 7.0±6.9 mm Hg in coarctation patients. Postrepair aneurysm patients had no late ruptures, and maximum diameter shrunk from 5.9±1.3 cm preoperatively to 4.8±1.3 cm. Estimated survival at 1, 5, and 8 years was 95%, 95%, and 90%, respectively. CONCLUSIONS: Coarctation, recurrent coarctation, and postrepair aneurysm/pseudoaneurysm in adolescent and adult patients can be safely and effectively managed with open, hybrid, or endovascular techniques. Optimal results are achievable in this complex population of patients with a multimodality approach tailored to surgical indication and anatomy. All survivors of coarctation repair require lifelong surveillance.

Insurance and education determine survival in infantile coarctation of the aorta.

Health outcomes are determined by case severity, physician decisions, and patient variables. In a population-based study between 1981 and 1989, 103 cases of infant coarctation of the aorta were diagnosed before one year of age. The goal of this study was to determine whether patient race, gender, income, and insurance status had effects on outcome of coarctation of the aorta that were distinct from the effect of case severity. Survival of infants with coarctation of the aorta, a common congenital cardiovascular malformation, is associated with greater maternal education and with having any health insurance but not with measures of severity. Infants without health insurance are 12.8 times more likely to die than infants with any health insurance. Fifty-five percent of all deaths in infant coarctation occur prior to surgical treatment. One-third of deaths occur without diagnosis. Outcome measures require knowledge of the entire population and of insurance status to inform policy.

Coarctation of the aorta in infants and neonates: results and assessment of prognostic variables.

From 1984 until 1994, 75 consecutive patients younger than 12 months of age were operated on for coarctation of the aorta. We retrospectively analyzed predictive factors for morbidity and mortality, and also interaction between surgical procedures and recoarctation. Surgical procedures were as follows: resection with a traditional end-to-end (E-E) anastomosis in 55 patients (73.3%), prosthetic patch aortoplasty (PPA) in 12 patients (16%) and subclavian flap aortoplasty (SFA) in 8 patients (10.7%). Early mortality was 9.33% (7 patients). Logistic regression analysis proved that age at operation, associated anomalies of heart, type of coarctation, aortic arch hypoplasia and pulmonary banding were independent predictors of hospital death. Late mortality occurred in 7 patients (10.3%). Associated anomalies of heart were an independent prognostic factor for late mortality. Actuarial freedom from recoarctation at 1 year was 91% [confidence limits (CL): 82% to 97%] and 5 years were 74% (CL: 67% to 86%). Immediate postrepair gradient was equal after E-E anastomosis and other procedures. We conclude that the treatment of first choice in the management of coarctation of the aorta in infants is E-E anastomosis.

Coarctation of the aorta: review of 362 operated patients. Long-term follow-up and assessment of prognostic variables.

362 patients operated upon for coarctation of the aorta from 1961-1980 were analyzed retrospectively. Age at operation was less than 2 years in 74 (group A) and greater than or equal to 2 years in 288 patients (group B). Associated cardiovascular malformations were common, especially in group A patients. Early mortality was 12.2% for group A and 1.4% for group B patients. 336 patients were followed for 6 months to 21 years (mean 8.9 years). Late mortality was 0.8% per patient year. Associated cardiac defects and postoperative hypertension were responsible for most of the late deaths. Late reoperations were performed because of aortic valve disease, residual coarctation (with persistent hypertension) and aortic aneurysms at the site of anastomosis. The incidence of hypertension decreased from 82.5% preoperatively to 33.5% at discharge from the hospital. It decreased further during follow-up in patients operated less than 10 years of age, but remained constant in the older patients. In conclusion, morbidity and mortality after operative repair of coarctation are determined mainly by (1) associated cardiac malformations, and (2) postoperative hypertension. Patients with isolated coarctation and postoperative normal blood pressure have an excellent prognosis. Patients operated upon from between 2-9 years of age carry the lowest risk for residual coarctation and late postoperative hypertension.